抗帕金森病药物及其作用靶点研究进展

[11] Gene therapy for Parkinson’s disease: a step closer?[J] . A Jon Stoessl.The Lancet . 2014

[12] Recent advances in Parkinson's disease genetics [J]. JOURNAL OF NEUROLOGY, 2014, 261 (02) : 259 - 266

[13] The prevalence and incidence of Parkinson’s disease in China: a systematic review and meta-analysis[J] . Chun-lin Ma,Li Su,Juan-juan Xie,Jian-xiong Long,Peng Wu,Lian Gu.Journal of Neural Transmission . 2014 (2)

[14] Double-Blind Study of the Actively Transported Levodopa Prodrug XP21279 in Parkinson's Disease [J]. MOVEMENT DISORDERS, 2014, 29 (01) : 75 - 82

[15] Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving Nitisinone[J] . Fatiha Bendadi,Tom J. de Koning,Gepke Visser,Hubertus C.M.T. Prinsen,Monique G.M. de Sain,Nanda Verhoeven-Duif,Gerben Sinnema,Francjan J. van Spronsen,Peter M. van Hasselt.The Journal of Pediatrics . 2013

[16] Kinetic Modeling, Test–Retest, and Dosimetry of 123I-MNI-420 in Humans[J] . Adriana Alexandre S. Tavares,Jeffery C. Batis,Caroline Papin,Danna Jennings,David Alagille,David S. Russell,Christine Vala,Hsiaoju Lee,Ronald M. Baldwin,I. George Zubal,Kenneth L. Marek,John P. Seibyl,Olivier Barret,Gilles D. Tamagnan.Journal of Nuclear Medicine . 2013 (10)

[17] α-Synuclein Elevation in Human Neurodegenerative Diseases: Experimental, Pathogenetic, and Therapeutic Implications[J] . Ayse Ulusoy,Donato A. Monte.Molecular Neurobiology . 2013 (2)

[18] Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease [J]. MOLECULAR GENETICS AND METABOLISM, 2012, 107 (04) : 690 - 699

[19] Two in one against motor neuron degeneration: tackling oxidative stress and inflammation with a sulfasalazine derivative[J] . Albrecht M. Clement.Journal of Neurochemistry . 2012 (5)

[20] Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 98 (02) : 286 - 291

[11] Gene therapy for Parkinson’s disease: a step closer?[J] . A Jon Stoessl.The Lancet . 2014

[12] Recent advances in Parkinson's disease genetics [J]. JOURNAL OF NEUROLOGY, 2014, 261 (02) : 259 - 266

[13] The prevalence and incidence of Parkinson’s disease in China: a systematic review and meta-analysis[J] . Chun-lin Ma,Li Su,Juan-juan Xie,Jian-xiong Long,Peng Wu,Lian Gu.Journal of Neural Transmission . 2014 (2)

[14] Double-Blind Study of the Actively Transported Levodopa Prodrug XP21279 in Parkinson's Disease [J]. MOVEMENT DISORDERS, 2014, 29 (01) : 75 - 82

[15] Impaired Cognitive Functioning in Patients with Tyrosinemia Type I Receiving Nitisinone[J] . Fatiha Bendadi,Tom J. de Koning,Gepke Visser,Hubertus C.M.T. Prinsen,Monique G.M. de Sain,Nanda Verhoeven-Duif,Gerben Sinnema,Francjan J. van Spronsen,Peter M. van Hasselt.The Journal of Pediatrics . 2013

[16] Kinetic Modeling, Test–Retest, and Dosimetry of 123I-MNI-420 in Humans[J] . Adriana Alexandre S. Tavares,Jeffery C. Batis,Caroline Papin,Danna Jennings,David Alagille,David S. Russell,Christine Vala,Hsiaoju Lee,Ronald M. Baldwin,I. George Zubal,Kenneth L. Marek,John P. Seibyl,Olivier Barret,Gilles D. Tamagnan.Journal of Nuclear Medicine . 2013 (10)

[17] α-Synuclein Elevation in Human Neurodegenerative Diseases: Experimental, Pathogenetic, and Therapeutic Implications[J] . Ayse Ulusoy,Donato A. Monte.Molecular Neurobiology . 2013 (2)

[18] Brain uptake of Tc99m-HMPAO correlates with clinical response to the novel redox modulating agent EPI-743 in patients with mitochondrial disease [J]. MOLECULAR GENETICS AND METABOLISM, 2012, 107 (04) : 690 - 699

[19] Two in one against motor neuron degeneration: tackling oxidative stress and inflammation with a sulfasalazine derivative[J] . Albrecht M. Clement.Journal of Neurochemistry . 2012 (5)

[20] Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2011, 98 (02) : 286 - 291